drugset / Trial / NCT04295486

Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

NCT04295486

Phase 2 Recruiting 5478 enrolled University of Miami
RandomizedParallel-groupOpen-labelPrevention

Summary

This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.

Timeline

Start
2021-03-01
Primary completion
2027-03-01
Completion
2027-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg